-The Times of India NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops. Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a...

-The Telegraph Calcutta: Private companies will be able to buy farm produce directly from farmers in Bengal. But the widely-anticipated whoop of exultation from Indian industry over the amendment in the state's agri-marketing act was somewhat muted because of the lack of clarity on the issue of contract farming and the absence of clear guidelines on whether the state government would provide incentives and help in the acquisition of land for private...

-The Hindu Business Line   Cases of prosecutions over wages, contract workers, child labour are down  Among key initiatives of the Narendra Modi government has been the fast-tracking of labour law reforms to put an end to ‘inspector raj' and improving the country's rank in the World Bank's ease of ‘doing business' index. However, when it comes to checking labour law violations, the number of inspections in the Central sphere, which includes banks, railways,...

-The Hindustan Times Two popular restaurant chains, KFC and Sagar Ratna, are serving rice dishes that have been found to be "unsafe" due to the presence of harmful artificial colouring, the Delhi government's food safety department has said in a report submitted to the high court. The "unsafe" dishes mentioned are fast-food giant KFC's Rizo Rice served at its restaurant at Scindia House in Connaught Place, and some rice recipes from South...

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...